Nationwide vaccination: A success story in Taiwan

Vaccine

Volumn 18, Issue SUPPL. 1, 2000, Pages

  Huang, Kun Yen ^a   Lin, Sheue Rong ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b Ministry of Health Taiwan   (Taiwan)

Author keywords

Carrier rate; Hepatitis B; Hepatocellular carcinoma; Taiwan; Vaccination programme

Indexed keywords

HEPATITIS B VACCINE;

DISEASE CARRIER; HEALTH PROGRAM; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; PREVALENCE; PRIORITY JOURNAL; REVIEW; TAIWAN; VACCINATION;

EID: 0033966594     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00460-0     Document Type: Article

References (17)

1. Department of Health. Health and vital statistics, Republic of China 1997. The Executive Yuan. 2:1998;7-10.
2. Sung J.-L. Hepatitis B virus infection and its sequelae in Taiwan. Gastroenterol. Japon. 19:1984;363-366.
3. Chen D.-S., Sung J.-L. Hepatitis B virus infection and chronic liver disease in Taiwan. Acta. Hepato-Gastroenterol. 25:1978;423-430.
4. Sung J.-L., Chen D.-S. Maternal transmission of hepatitis B surface antigen in patients with hepatocellular carcinoma in Taiwan. Scand. J. Gastroenterol. 15:1980;321-324.
5. Sung J.-L., Chen D.-S., Lai M.-Y., et al. Epidemiological study on hepatitis B virus infection in Taiwan. Chin. J. Gastroenterol. 1:1984;1-9.
6. Wu J.-S., Chen C.-H., Chiang Y.-H., et al. Hepatitis B virus infection in Taiwan. J. Formosan. Med. Assoc. 79:1980;760-767.
7. Stevens C.E., Palmer Beasley R., Tsui J., Lee W.-C. Vertical transmission of hepatitis B antigen in Taiwan. N. Engl. J. Med. 292:1975;771-774.
8. Palmer Beasley R. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma - epidemiologic considerations. Hepatology. 2:(Suppl):1982;S21-S26.
9. Palmer Beasley R., Trepo C., Stevens C.E., Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am. J. Epidemiol. 105:1977;94-98.
10. Palmer Beasley R., Hwang L.-Y., Lee G.C.-Y., et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 2:1983;1099-1102.
11. Palmer Beasley R., Hwang L.-Y., Szmuness W., et al. HBIG prophylaxis for perinatal HBV infections-final report of the Taiwan trial. Papaevangelou G., Hennessen W. Viral hepatitis: Standardization in immunoprophylaxis of infection by hepatitis viruses. Develop. Biol. Stand. 54:1983;363-375.
12. Lo K.-J., Tsai Y.-T., Lee S.-D., et al. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J. Infect. Dis. 152:1985;817-822.
13. Hsu H.-M., Chen D.-S., Chuang C.-H., et al. The Hepatitis Control Committee and The Hepatitis Steering Committee. Efficacy of a mass hepatitis B vaccination program in Taiwan. JAMA. 260:1988;2231-2235.
14. Hsu H.-M., Lu C.-F., Lee S.-C., Lin S.-R., Chen D.-S. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: The effect of hepatitis B mass immunization. J. Infect. Dis. 179:1999;367-370.
15. Chen H.-L., Chang M.-H., Ni Y.-H., et al. Seroepidemiology of hepatitis B virus infection in children - ten years of mass vaccination in Taiwan. JAMA. 276:1996;906-908.
16. Chang M.-H., Chen C.-J., Lai M.-S., Hsu H.-M., Wu T.-C., Kong M.-S., Liang D.-C., Shau W.-Y., Chen D.-S., Taiwan Childhood Hepatoma Study Group. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med. 336:1997;1855-1859.
17. Department of Health. Public health in Taiwan, Republic of China. The Executive Yuan. 2:1998;57-59.